| 1 |
17624531 | Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. | 2008 Apr |
2 |
| 2 |
15292932 | No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan. | 2004 Sep 13 |
2 |
| 3 |
9748119 | Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002. | 1998 Sep |
2 |
| 4 |
9334824 | Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice. | 1997 Sep 26 |
2 |
| 5 |
8633248 | Preclinical evaluation of CPT-11 and its active metabolite SN-38. | 1996 Feb |
2 |
| 6 |
7494232 | Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. | 1995 Dec 20 |
3 |
| 7 |
7733646 | Combined effects of hyperthermia and CPT-11 on DNA strand breaks in mouse mammary carcinoma FM3A cells. | 1995 Jan-Feb |
1 |
| 8 |
8089365 | Effect of peplomycin or camptothecin-11 on X-ray skin injuries of ICR hairless mice. | 1994 Jul |
1 |
| 9 |
1309380 | A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer. | 1992 Jan |
2 |
| 10 |
1332623 | [DNA topoisomerase inhibitor]. | 1992 Nov |
1 |